Insider Transactions by Versant Venture Capital V, L.P.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
TSBXTurnstone Biologics Corp.Versant Venture Capital V, L.P.10% OwnerJul 25, 2023Buy$12.006,57578,90090,888Jul 27, 2023, 04:23 PM
TSBXTurnstone Biologics Corp.Versant Venture Capital V, L.P.10% OwnerJul 25, 2023Buy$12.0015,028180,336207,486Jul 27, 2023, 04:23 PM
TSBXTurnstone Biologics Corp.Versant Venture Capital V, L.P.10% OwnerJul 25, 2023Buy$12.00197,4582,369,4962,726,322Jul 27, 2023, 04:23 PM
TSBXTurnstone Biologics Corp.Versant Venture Capital V, L.P.10% OwnerJul 25, 2023Buy$12.005,93971,26882,006Jul 27, 2023, 04:23 PM
RPTXRepare Therapeutics Inc.Versant Venture Capital V, L.P.10% OwnerJun 03, 2022Sale$12.25750,0009,188,7752,344,451Jun 07, 2022, 04:36 PM
RPTXRepare Therapeutics Inc.Versant Venture Capital V, L.P.10% OwnerJun 23, 2020Buy$20.00250,0005,000,0003,419,451Jun 25, 2020, 06:46 PM
APREAprea Therapeutics, Inc.Versant Venture Capital V, L.P.10% OwnerOct 07, 2019Buy$15.00333,3334,999,995333,333Oct 07, 2019, 07:39 PM
CRSPCRISPR Therapeutics AGVersant Venture Capital V, L.P.10% OwnerApr 24, 2018Sale$50.9922,8411,164,6551,519,505Apr 26, 2018, 04:44 PM
CRSPCRISPR Therapeutics AGVersant Venture Capital V, L.P.10% OwnerApr 23, 2018Sale$50.68101,9945,168,9011,539,576Apr 24, 2018, 07:44 PM
CRSPCRISPR Therapeutics AGVersant Venture Capital V, L.P.10% OwnerOct 24, 2016Buy$14.00161,0002,254,0004,104,045Dec 23, 2016, 06:03 PM
CRSPCRISPR Therapeutics AGVersant Venture Capital V, L.P.10% OwnerOct 24, 2016Option Exercise$14.00161,0002,254,0004,104,045Oct 26, 2016, 06:28 PM